How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?

Thumbnail
View/Open
Full Text
Date
2014-05-01
Author
Sexton, D. J.
Metadata
Show full item record
Usage
This item's downloads: 0 (view details)
Cited 2 times in Scopus (view citations)

Recommended Citation
Sexton, D. J. (2014). How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?. Circulation: Heart Failure 7 (3), 536-536
Published Version
URI
http://hdl.handle.net/10379/13867
Collections
Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland